Search research articles
Contact Us
Filters
Showing results (21-30 of 167) with videos related to
Page
of 17
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 16, 2023
The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis
Matthias Lenfant, Bram Verstockt, João Sabino, et al.
Expert Opinion on Drug Safety
|
June 3, 2017
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases
Bram Verstockt, Barbara Deleenheer, Gert Van Assche, et al.
Gut
|
September 28, 2022
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?
Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, et al.
Inflammatory Bowel Diseases
|
November 9, 2021
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD
Annick Moens, Bram Verstockt, Dahham Alsoud, et al.
Current Opinion in Pharmacology
|
August 9, 2024
Preoperative optimization: Review on nutritional assessment and strategies in IBD
Julie Vanderstappen, Sien Hoekx, Gabriele Bislenghi, et al.
The American Journal of Gastroenterology
|
September 27, 2023
Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis
Dahham Alsoud, Jessica Ho, João Sabino, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
An unusual cause of severe, persistent diarrhoea
Bram Verstockt, Barbara Deleenheer, Filip Sermon, et al.
European Journal of Gastroenterology & Hepatology
|
September 5, 2022
Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center
Annick Moens, Dahham Alsoud, Bram Verstockt, et al.
Current Opinion in Pharmacology
|
October 17, 2025
Shaping surgical decisions in IBD - Unveiling the power of intestinal ultrasound across the perioperative pathway
Hanne Theys, Elisabeth Eggermont, Simon Vancoillie, et al.
Therapeutic Advances in Gastroenterology
|
April 20, 2026
Patterns of conventional therapy use and advanced therapy initiation drivers in inflammatory bowel disease
Tim Raine, Christian Agboton, Alex Geddes, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 167) with videos related to
Sort By:
Page
of 17
Alimentary Pharmacology & Therapeutics
|
October 16, 2023
The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis
Matthias Lenfant, Bram Verstockt, João Sabino, et al.
Expert Opinion on Drug Safety
|
June 3, 2017
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases
Bram Verstockt, Barbara Deleenheer, Gert Van Assche, et al.
Gut
|
September 28, 2022
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?
Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, et al.
Inflammatory Bowel Diseases
|
November 9, 2021
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD
Annick Moens, Bram Verstockt, Dahham Alsoud, et al.
Current Opinion in Pharmacology
|
August 9, 2024
Preoperative optimization: Review on nutritional assessment and strategies in IBD
Julie Vanderstappen, Sien Hoekx, Gabriele Bislenghi, et al.
The American Journal of Gastroenterology
|
September 27, 2023
Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis
Dahham Alsoud, Jessica Ho, João Sabino, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
An unusual cause of severe, persistent diarrhoea
Bram Verstockt, Barbara Deleenheer, Filip Sermon, et al.
European Journal of Gastroenterology & Hepatology
|
September 5, 2022
Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center
Annick Moens, Dahham Alsoud, Bram Verstockt, et al.
Current Opinion in Pharmacology
|
October 17, 2025
Shaping surgical decisions in IBD - Unveiling the power of intestinal ultrasound across the perioperative pathway
Hanne Theys, Elisabeth Eggermont, Simon Vancoillie, et al.
Therapeutic Advances in Gastroenterology
|
April 20, 2026
Patterns of conventional therapy use and advanced therapy initiation drivers in inflammatory bowel disease
Tim Raine, Christian Agboton, Alex Geddes, et al.
Page
of 17